Tricog Health is a cardiac AI healthtech startup with primary operations in Bengaluru, India, that provides cloud-based ECG and echo analysis for clinics, hospitals and diagnostic centres.

This Startup Deep Dive explains what Tricog Health does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Tricog Health in Brief

• What it is: Tricog Health is an Indian AI cardiac diagnostics company based in Bengaluru.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Tricog's InstaECG sends ECG data from a cloud-connected device to AI analysis, which cardiologists verify, with reports in minutes.
• It also offers InstaEcho for AI-based echocardiogram analysis, plus VCardia and KeeboHealth remote patient management offerings.
• Customers include clinics, hospitals and diagnostic centres mainly in India, Southeast Asia and Africa.
• Funding: Reports differ: about $23 million across four rounds, $25.54 million across 8 rounds, $30 million, or Rs 132 crore (reported).

Tricog Health Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Tricog Health?

Tricog Health operates in the AI cardiac diagnostics space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Tricog Health.

• Tricog's InstaECG sends ECG data from a cloud-connected device to AI analysis, which cardiologists verify, with reports in minutes.
• It also offers InstaEcho for AI-based echocardiogram analysis, plus VCardia and KeeboHealth remote patient management offerings.
• Customers include clinics, hospitals and diagnostic centres mainly in India, Southeast Asia and Africa.

The Origin Story of Tricog Health

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Charit Bhograj, Zainul Charbiwala, Udayan Dasgupta, Abhinav Gujjar.
• Founders named in most sources are Charit Bhograj (CEO), Zainul Charbiwala, Udayan Dasgupta and Abhinav Gujjar; one report lists only three. The founding year is reported as 2014 or 2015.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the AI cardiac diagnostics sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• c. 2017: Series A led by Inventus Capital Partners and Blume Ventures, amount undisclosed (reported).
• 2019-2020: Series B of $10-10.5 million (reports differ).
• April 2023: $8.5 million Series B2 led by Omron Healthcare and Sony Innovation Fund (reported).
• October 2026: reported collaboration with Sanofi and deeper ties with OMRON Healthcare.

Tricog Health Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Series A c. 2017 led by Inventus and Blume, undisclosed (reported).
• Series B: $10.5 million with UTEC, Aflac Ventures, TeamFund, Dream Incubator plus Inventus and Blume per one report; another says $10 million in 2019 (reported).
• Series B2 of $8.5 million in April 2023 led by Omron Healthcare and Sony Innovation Fund, with UTEC, Inventus and SG Innovate (reported).

How Does Tricog Health Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Sells cloud-connected cardiac diagnostics and AI reporting with cardiologist verification to healthcare providers.

The Numbers: Tricog Health Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Patient reach figures differ: over 12 million screened per one profile, over 40 million per a later article (company-stated).

Market Opportunity for Tricog Health

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Operations are concentrated in India, Southeast Asia and Africa.

Technology and Product at Tricog Health

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• AI algorithms analyse ECG data, with cardiologists verifying the results.

Team and Culture at Tricog Health

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Leadership: Charit Bhograj, Zainul Charbiwala, Udayan Dasgupta, Abhinav Gujjar are named as founders.
• Further detail on the wider team is limited in public sources.

Tricog Health Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Tricog Health

• Reported funding totals and reach figures conflict across sources.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.
• Data privacy risk: health records are sensitive, and breaches or misuse can bring legal and reputational harm.
• Thin margins: low-ticket services and heavy customer-acquisition spend can keep unit economics weak.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Tricog Health Growth Outlook: What to Watch

• Reported focus on international expansion with Sanofi and OMRON Healthcare.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Tricog Health can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Tricog Health Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Tricog Health

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Tricog Health.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Tricog Health

Studying a company in the AI cardiac diagnostics space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Tricog Health.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Tricog Health as a Startup

• Customer clarity: Can Tricog Health name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Tricog Health is part of India’s growing AI cardiac diagnostics ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Tricog Health FAQs: Frequently Asked Questions

What is Tricog Health?

Tricog Health is a cardiac AI healthtech startup with primary operations in Bengaluru, India, that provides cloud-based ECG and echo analysis for clinics, hospitals and diagnostic centres. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Tricog Health?

Tricog Health was founded by Charit Bhograj, Zainul Charbiwala, Udayan Dasgupta, Abhinav Gujjar, and the company reports a founding year of 2014.

How much funding has Tricog Health raised?

Reports differ: about $23 million across four rounds, $25.54 million across 8 rounds, $30 million, or Rs 132 crore (reported). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Tricog Health make money?

Tricog Health earns revenue from its AI cardiac diagnostics products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Tricog Health?

Reported rivals include Cardiologs, Cardiomatics, Anumana. See the competitor comparison above for how they differ.

What are the main risks for Tricog Health?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Satlabs Space Systems — Satlabs raises about $1M for floating ground stations | Tata 1mg — Tata 1mg: Rs 2,392 Cr FY25 revenue, loss narrowing. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.